Tamoxifen Citrate

CAS: 54965-24-1

Ref. TR-T006090

Produktinformation

• Name: Tamoxifen Citrate
• Synonyme: Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1), Ethanamine, 2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-, (Z)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1), Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (9CI), I.C.I.46474 citrate, ICI 46474, Istubal, Kessar, Noltam, Nolvadex, Nourytam, Soltamox, TMX, Tamofen, Tamoplex, Tamox-Puren, Tomaxasta, Valodex, Z-Tamoxifen citrate
• Marke: TRC
• Beschreibung: Applications Tamoxifen Citrate is a selective estrogen response modifier (SERM), protein kinase C inhibitor and anti-angiogenetic factor. Tamoxifen is a prodrug that is metabolized to active metabolites 4-hydroxytamoxifen (4-OHT) and endoxifen by cytochrome P450 isoforms CYP2D6 and CYP3A4.References Sutherland, R., et al.: Nature, 267, 434 (1977), Lerner, L., et al.: Cancer Res., 50, 4177 (1990), Love, R., et al.: J. Clin. Oncol., 20 2559 (2002),

Chemische Eigenschaften

• Molekulargewicht: 563.64
• Formel: C₂₆H₂₉NO·C₆H₈O₇
• Farbe/Form: White
• InChl: InChI=1S/C26H29NO.C6H8O7/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3;7-3(8)1-6(13,5(11)12)2-4(9)10/h5-18H,4,19-20H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/b26-25-
• InChI Key: InChIKey=GWSBKGMZNRHLRW-YNEISZPASA-N
• SMILES: C[C@]12CCC(=O)C=C1CC[C@@H]1C2[C@H](O)CC2[C@H]1CC[C@]2(O)C(=O)CO